Our Research Symposium
Neuroblastoma UK hosts a biennial Neuroblastoma Research Symposium bringing together researchers, clinicians and charity representatives from across the UK, Europe and further afield. The day and a half conference provides a platform for both established and junior researchers to present their work and encourages discussion and collaboration.
Latest Research News
The trial is sponsored and centrally coordinated by Institute Gustave Roussy in Paris and is currently open to recruitment in 17 countries. The trial is open and recruiting in 20 of 21 UK children’s oncology centres apart from one.
Neuroblastoma UK has awarded three Innovation Grants, formally known as Small Grants, in 2025 and late 2024 to support fresh, early-stage research that could pave the way for better treatments for children with neuroblastoma.
In 2013, Neuroblastoma UK joined forces with several other charities to fund the UK component of a unique international study into Opsoclonus Myoclonus Syndrome (OMS). This study was called the UK Multicentre Study of Children with Opsoclonus Myoclonus Syndrome (UMSCOM).
As part of Neuroblastoma UK’s 2024 Grant Round, Dr. Olga Piskareva, alongside an international team of researchers received £208,887 to conduct research into the mRNA vaccine.
The 1st Neuroblastoma Research Symposium was held on Friday, 3rd December 2010 at the Cancer Research UK Cambridge Research Institute, Cambridge. The programme focussed on new treatments.